Wanyong Zeng

Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

F. Stephen Hodi, Donald P. Lawrence, Cecilia Lezcano et al. · Cancer Immunology Research · 2014 · 595 citations · Full text

Immunology, Immunoediting, Pathology +16

Adoptive Transfer of Invariant NKT Cells as Immunotherapy for Advanced Melanoma: A Phase I Clinical Trial

Mark A. Exley, Phillip Friedlander, Nadia Alatrakchi et al. · Clinical Cancer Research · 2017 · 164 citations · Full text

The Cytosolic Endopeptidase, Thimet Oligopeptidase, Destroys Antigenic Peptides and Limits the Extent of MHC Class I Antigen Presentation

Ian A. York, Annie X. Mo, Kristen Lemerise et al. · Immunity · 2003 · 153 citations · Full text

Destroys Antigenic Peptides, Autoimmune Disease, Allergy +10

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells

Ute Burkhardt, Ursula Hainz, Kristen E. Stevenson et al. · Journal of Clinical Investigation · 2013 · 75 citations

CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients

Linda A. Lieberman, Wanyong Zeng, Carol M. Singh et al. · Neurology · 2015 · 50 citations · Full text